文献速递精神分裂症与精神病性障碍儿童青少年精神

母体免疫激活子代认知缺陷中精神分裂症风险基因甲基化的发育调控

Developmental modulation of schizophrenia risk gene methylation in offspring exhibiting cognitive deficits following maternal immune activation.
PubMed 文献 · Mol Psychiatry · 2025-08-29

本研究聚焦于母体免疫激活(MIA)后出现认知障碍的子代,在产前和产后阶段检测皮层中SAM/SAH比值、DNMT表达与活性及DNA甲基化模式。发现MIA在胎儿皮层增加SAM/SAH比值并升高DNMT表达与活性,出生后消失但成年期重新出现,伴随认知缺陷及与精神分裂症风险相关的DNA甲基化改变。

要点

  • MIA子代胎儿皮层甲基化能力增强,DNMT表达与活性升高。
  • 上述变化出生后消失,成年期重新出现并与认知缺陷同步。
  • 成年期DNA甲基化模式改变,差异甲基化基因富集于神经发育和信号通路。

核心结论

  • MIA诱导的甲基化通路改变在子代中呈发育阶段性动态,成年期重现并与认知缺陷相关。

研究设计与样本

  • 研究检测MIA暴露子代产前和产后皮层中SAM/SAH比值、DNMT表达与活性及DNA甲基化模式。

主要发现

  • MIA增加胎儿皮层SAM/SAH比值并升高DNMT表达与活性。
  • 这些变化出生后未出现,但在成年期重新出现,与认知缺陷同时发生。
  • 成年期甲基化通路改变伴随DNA甲基化模式改变,差异甲基化基因与精神分裂症风险相关并富集于神经发育和神经元信号通路。

临床怎么用

  • 提示甲基化通路动态变化可能为精神分裂症认知症状提供潜在干预靶点。

局限性

  • 原文未明确报告样本量、统计阈值或效应值等具体数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Maternal infection during pregnancy has been shown in epidemiological studies to increase the risk of neurodevelopmental disorders, like schizophrenia, in the developing fetus. Epigenetic mechanisms are thought to play a crucial role in linking maternal immune activation (MIA) to a higher risk of schizophrenia in offspring by disrupting normal brain development. However, our knowledge of how these epigenetic mechanisms are altered and contribute to abnormal neurodevelopment remains limited. This lack of understanding has slowed progress in identifying therapeutic targets in particular for cognitive symptoms of neurodevelopmental disorders. Focusing on the cortex of offspring exposed to MIA who showed cognitive impairments, at both prenatal and postnatal stages, here we measured tissue concentrations of S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH), using the SAM/SAH ratio as an indicator of overall methylation capacity. We also analyzed changes in the expression and activity of DNA methyltransferases (DNMTs), as well as DNA methylation (DNAm) patterns. Our findings revealed that MIA increased the SAM/SAH ratio and elevated both DNMT expression and activity in the fetal cortex. Surprisingly, these changes were not present after birth but resurfaced in adulthood, coinciding with cognitive deficits. These methylation pathway changes in adulthood were accompanied by altered DNAm patterns, with differentially methylated genes linked to schizophrenia risk and enriched in pathways related to neurodevelopment and neuronal signalling. These novel insights help establish a critical connection between MIA and epigenetic changes that contribute to cognitive deficits similar to those observed in schizophrenia.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Woods RM, Potter HG, Kowash HM, et al. Developmental modulation of schizophrenia risk gene methylation in offspring exhibiting cognitive deficits following maternal immune activation. Mol Psychiatry. 2025. PMID: 40883450. doi:10.1038/s41380-025-03147-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。